Study Details

The purpose of this survey is to better understand how sites conducting clinical trials have shifted from traditional to decentralized and hybrid methods. This includes which decentralized methods have been adopted, as well as any difficulties or barriers your clinical research site faces. For example, during the COVID-19 pandemic, 80% of non-COVID-19 trials were stopped or interrupted. Some sites were able to adapt by adopting digital and remote solutions, such as telehealth or using electronic devices to monitor the patient’s health. 

You will be asked basic questions about your background, medical field, involvement in clinical trials, and your opinion and experience on how clinical trials have changed in the last year due to COVID-19. Only participate in this survey if you are involved in (or have previously been involved in) conducting clinical trials.